Zoetis
5 Giralda Farms
Madison
New Jersey
07940
United States
Tel: 973660-7491
Website: http://www.zoetis.com/
221 articles about Zoetis
-
Zoetis to Participate in the Barclays Global Healthcare Conference - March 5 2024
3/5/2024
Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024.
-
Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit
2/21/2024
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024.
-
Blacksmith Medicines and Zoetis Announce Research Collaboration for Novel Animal Health Antibiotics
2/14/2024
Blacksmith Medicines, Inc. and Zoetis announced a collaboration to discover and develop novel antibiotics for animal health.
-
Zoetis Declares Second Quarter 2024 Dividend
2/6/2024
The Board of Directors of Zoetis Inc. has declared a dividend of $0.432 per share for the second quarter of 2024.
-
Zoetis to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
9/6/2023
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, Sept. 12, 2023.
-
Media Advisory: Ribbon-cutting Ceremony for new Zoetis facility in Durham, N.C., to expand diagnostics R&D and engineering capabilities and bring more jobs to Durham
8/23/2023
Zoetis, the world’s leading animal health company, is pleased to invite members of the media to attend a ribbon-cutting event to mark the official opening of a new building dedicated to diagnostics and biodevices research and development to meet the needs of veterinarians, livestock farmers and pet owners.
-
Zoetis Announces Appointment of Ester Banque as President of U.S. Operations for World Leader in Animal Health
7/10/2023
Zoetis Inc. (NYSE:ZTS) today announced the addition of Ester Banque as Executive Vice President and President, U.S. Operations, for the company, effective July 10, 2023.
-
Zoetis to Host Webcast and Conference Call on Second Quarter 2023 Financial Results
6/30/2023
Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Aug. 8, 2023. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review second quarter 2023 financial results and respond to questions from financial analysts during the call.
-
Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs
5/5/2023
Zoetis Inc. announced that the U.S. Food and Drug Administration has approved Librela™ for the control of pain associated with osteoarthritis in dogs.
-
Zoetis Announces First Quarter 2023 Results
5/4/2023
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2023 and maintained its guidance for full year 2023.
-
Zoetis Reports Fourth Quarter and Full Year 2022 Results
2/14/2023
Zoetis Inc. (NYSE:ZTS) today reported its financial results for the fourth quarter and full year 2022 and provided full year guidance for 2023.
-
EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™
1/10/2023
EpiVax, Inc. ("EpiVax") and Zoetis, are pleased to announce an exclusive collaboration to develop CircoMatch™, a unique bioinformatics tool that predicts the coverage of Porcine Circovirus Type 2 (PCV2) vaccines against field isolates of PCV2.
-
Zoetis Declares First Quarter 2023 Dividend; Board Approves 15% Payment Increase
12/8/2022
The Board of Directors of Zoetis Inc. has declared a dividend of $0.375 per share for the first quarter of 2023, an increase of 15% from the quarterly dividend rate paid in 2022.
-
Zoetis to Participate in the Piper Sandler 34th Annual Healthcare Conference
11/29/2022
Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022.
-
Zoetis Announces Third Quarter 2022 Results
11/3/2022
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2022.
-
Zoetis Declares Fourth Quarter 2022 Dividend
10/13/2022
The Board of Directors of Zoetis Inc. has declared a dividend of $0.325 per share for the fourth quarter of 2022.
-
Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products
9/30/2022
Zoetis Inc today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals.
-
Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results
9/29/2022
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022.
-
Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
9/9/2022
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022.
-
Zoetis Announces Second Quarter 2022 Results
8/4/2022
Zoetis Inc. reported its financial results for the second quarter of 2022 and updated its guidance for full year 2022 to reflect its positive outlook for the remainder of the year, as well as the negative impact of recent changes to foreign exchange rates.